Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments (Tables)

v3.24.3
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2024
Fair Value of Financial Instruments [Abstract]  
Schedule of Fair Value of Our Financial Assets and Liabilities The following table summarizes the fair value of our financial assets and liabilities that were accounted for at fair value on a recurring basis, by level within the fair value hierarchy:
    September 30, 2024  
    Level 1     Level 2     Level 3     Fair Value  
Assets:                        
Cash equivalents:                        
Money market funds     20,325      
-
     
-
      20,325  
Foreign exchange contracts receivable    
-
      15      
-
      15  
      20,325       15      
-
      20,340  
Liabilities:                                
Contingent consideration    
-
     
-
      161       161  
Private Placement Warrants    
-
     
-
      4,328       4,328  
     
-
     
-
      4,489       4,489  
    December 31, 2023  
    Level 1     Level 2     Level 3       Fair Value  
Assets:                        
Cash equivalents:                        
Money market funds     11,377      
-
     
-
      11,377  
Foreign exchange contracts receivable             256      
-
      256  
      11,377       256      
-
      11,633  
Liabilities:                                
Contingent consideration    
-
     
-
      155       155  
     
-
     
-
      155       155  
Schedule of Fair Value Level 3 financial liabilities The changes in the fair value of the Company’s Level 3 financial liabilities, which are measured on a recurring basis are as follows:
    Nine Months Ended
September 30,
2024
    Nine Months Ended
September 30,
2023
 
Beginning balance  
-
   
    -
 
Private Placement Warrants     28,745      
      -
 
Change in fair value     (24,417 )    
-
 
Ending balance     4,328      
-
 
Schedule of Fair Value of the Liabilities for the Private Placement Warrants The main assumptions used are as follows:
    September 30,
2024
    December 31,
2023
 
Underlying value of Common Stock ($)     1.02      
       -
 
Exercise price ($)     2.31      
-
 
Expected volatility (%)     117.6      
-
 
Expected terms (years)     1.75      
-
 
Risk-free interest rate (%)     3.6      
-